Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001423029-25-000005

Chief Executive Officer sold 85,000 shares at an average $64.04 ($5,443,462)

From the SEC's structured data for this filing

Trades in this filing

Anzalone Christopher Richard · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-17 Sale : show line 1 in the form −46,287 $63.55 $2,941,539 3,870,670 D
2025-12-17 Sale : show line 2 in the form −35,750 $64.51 $2,306,233 3,834,920 D
2025-12-17 Sale : show line 3 in the form −982 $65.53 $64,350 3,833,938 D
2025-12-17 Sale : show line 4 in the form −1,981 $66.30 $131,340 3,831,957 D
Open-market sales · 85,000 sh · avg $64.04 · $5,443,462
Loading xslF345X05/wk-form4_1766188590.xml…